1-235448220-CA-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_152490.5(B3GALNT2):​c.*1985delT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.175 in 506,400 control chromosomes in the GnomAD database, including 46 homozygotes. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.062 ( 45 hom., cov: 24)
Exomes 𝑓: 0.19 ( 1 hom. )

Consequence

B3GALNT2
NM_152490.5 3_prime_UTR

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.40

Publications

0 publications found
Variant links:
Genes affected
B3GALNT2 (HGNC:28596): (beta-1,3-N-acetylgalactosaminyltransferase 2) This gene encodes a member of the glycosyltransferase 31 family. The encoded protein synthesizes GalNAc:beta-1,3GlcNAc, a novel carbohydrate structure, on N- and O-glycans. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Mar 2013]
TBCE (HGNC:11582): (tubulin folding cofactor E) Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
TBCE Gene-Disease associations (from GenCC):
  • hypoparathyroidism-retardation-dysmorphism syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • encephalopathy, progressive, with amyotrophy and optic atrophy
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, ClinGen, G2P, Ambry Genetics
  • autosomal recessive Kenny-Caffey syndrome
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 1-235448220-CA-C is Benign according to our data. Variant chr1-235448220-CA-C is described in ClinVar as Benign. ClinVar VariationId is 1242668.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0796 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152490.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GALNT2
NM_152490.5
MANE Select
c.*1985delT
3_prime_UTR
Exon 12 of 12NP_689703.1Q8NCR0-1
TBCE
NM_003193.5
MANE Select
c.1400-109delA
intron
N/ANP_003184.1Q15813-1
TBCE
NM_001287801.2
c.1553-109delA
intron
N/ANP_001274730.1Q15813-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GALNT2
ENST00000366600.8
TSL:1 MANE Select
c.*1985delT
3_prime_UTR
Exon 12 of 12ENSP00000355559.3Q8NCR0-1
TBCE
ENST00000642610.2
MANE Select
c.1400-109delA
intron
N/AENSP00000494796.1Q15813-1
ENSG00000285053
ENST00000647186.1
c.1400-109delA
intron
N/AENSP00000494775.1

Frequencies

GnomAD3 genomes
AF:
0.0616
AC:
4038
AN:
65546
Hom.:
45
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0829
Gnomad AMI
AF:
0.102
Gnomad AMR
AF:
0.0417
Gnomad ASJ
AF:
0.0490
Gnomad EAS
AF:
0.0150
Gnomad SAS
AF:
0.0339
Gnomad FIN
AF:
0.0842
Gnomad MID
AF:
0.0362
Gnomad NFE
AF:
0.0535
Gnomad OTH
AF:
0.0500
GnomAD4 exome
AF:
0.192
AC:
84760
AN:
440836
Hom.:
1
AF XY:
0.190
AC XY:
45393
AN XY:
238636
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.144
AC:
1538
AN:
10714
American (AMR)
AF:
0.189
AC:
4299
AN:
22702
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
2512
AN:
14734
East Asian (EAS)
AF:
0.234
AC:
6248
AN:
26686
South Asian (SAS)
AF:
0.166
AC:
8063
AN:
48582
European-Finnish (FIN)
AF:
0.203
AC:
5726
AN:
28274
Middle Eastern (MID)
AF:
0.136
AC:
390
AN:
2870
European-Non Finnish (NFE)
AF:
0.195
AC:
51227
AN:
262438
Other (OTH)
AF:
0.200
AC:
4757
AN:
23836
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.310
Heterozygous variant carriers
0
5563
11126
16689
22252
27815
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0616
AC:
4038
AN:
65564
Hom.:
45
Cov.:
24
AF XY:
0.0632
AC XY:
1932
AN XY:
30564
show subpopulations
African (AFR)
AF:
0.0828
AC:
1729
AN:
20874
American (AMR)
AF:
0.0416
AC:
236
AN:
5672
Ashkenazi Jewish (ASJ)
AF:
0.0490
AC:
80
AN:
1634
East Asian (EAS)
AF:
0.0150
AC:
25
AN:
1664
South Asian (SAS)
AF:
0.0341
AC:
54
AN:
1584
European-Finnish (FIN)
AF:
0.0842
AC:
209
AN:
2482
Middle Eastern (MID)
AF:
0.0397
AC:
5
AN:
126
European-Non Finnish (NFE)
AF:
0.0535
AC:
1620
AN:
30294
Other (OTH)
AF:
0.0494
AC:
43
AN:
870
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
142
283
425
566
708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00879
Hom.:
2

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59405398; hg19: chr1-235611535; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.